Future studies can be expected to further provide information on such molecular mediators, e.g., the recently characterized CPT1C, as these may represent a more specific target for the regulation of endocannabinoid levels in the context of obesity and other metabolic disorders. The gene discussed is CPT1C; the disease is Other metabolic disease.